FDA’s Sentinel Strategy: Starting Slow Move Toward “Active” Surveillance
US FDA’s strategic plan for Sentinel includes pilot projects to move towards the vision of active surveillance. However, FDA is also making clear that it won’t be a quick or easy transformation.
You may also be interested in...
User fee program inflation adjustment also proposed to be changed to account for only PDUFA-related personnel.
Amazon, Microsoft, IBM among those helping build new operations and innovation centers for the US FDA's safety surveillance system.
Contracts for up to $220m to develop three new Sentinel centers will be awarded in September.